Sep 9, 2026•1 min read
FDA Approves ANDA089116 for BROMPHERIL Extended-Release Tablet
FDA approved ANDA089116 for BROMPHERIL, an oral extended-release tablet containing 6 mg dexbrompheniramine maleate and 120 mg pseudoephedrine sulfate, submitted by Copley Pharm; product is listed as discontinued.